114 related articles for article (PubMed ID: 30276218)
1. OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics.
Van Belle K; Herman J; Waer M; Sprangers B; Louat T
J Immunol Res; 2018; 2018():2505818. PubMed ID: 30276218
[TBL] [Abstract][Full Text] [Related]
2. The Novel Small Molecule Inhibitor, OSU-T315, Suppresses Vestibular Schwannoma and Meningioma Growth by Inhibiting PDK2 Function in the AKT Pathway Activation.
Mercado-Pimentel ME; Igarashi S; Dunn AM; Behbahani M; Miller C; Read CM; Jacob A
Austin J Med Oncol; 2016; 3(1):. PubMed ID: 27642646
[TBL] [Abstract][Full Text] [Related]
3. Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target.
Shirley LA; McCarty S; Yang MC; Saji M; Zhang X; Phay J; Ringel MD; Chen CS
Surgery; 2016 Jan; 159(1):163-70. PubMed ID: 26549818
[TBL] [Abstract][Full Text] [Related]
4. OSU-T315 and doxorubicin synergistically induce apoptosis via mitochondrial pathway in bladder cancer cells.
Li Z; Ren D; Chen C; Sun L; Fang K
Cell Biol Int; 2022 Oct; 46(10):1672-1681. PubMed ID: 35830716
[TBL] [Abstract][Full Text] [Related]
5. OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells.
Liu TM; Ling Y; Woyach JA; Beckwith K; Yeh YY; Hertlein E; Zhang X; Lehman A; Awan F; Jones JA; Andritsos LA; Maddocks K; MacMurray J; Salunke SB; Chen CS; Phelps MA; Byrd JC; Johnson AJ
Blood; 2015 Jan; 125(2):284-95. PubMed ID: 25293770
[TBL] [Abstract][Full Text] [Related]
6. T315 Decreases Acute Myeloid Leukemia Cell Viability through a Combination of Apoptosis Induction and Autophagic Cell Death.
Chiu CF; Weng JR; Jadhav A; Wu CY; Sargeant AM; Bai LY
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537872
[TBL] [Abstract][Full Text] [Related]
7. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
[TBL] [Abstract][Full Text] [Related]
8. OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma.
Gao M; Yeh PY; Lu YS; Hsu CH; Chen KF; Lee WC; Feng WC; Chen CS; Kuo ML; Cheng AL
Cancer Res; 2008 Nov; 68(22):9348-57. PubMed ID: 19010909
[TBL] [Abstract][Full Text] [Related]
9. OSU-03012 promotes caspase-independent but PERK-, cathepsin B-, BID-, and AIF-dependent killing of transformed cells.
Yacoub A; Park MA; Hanna D; Hong Y; Mitchell C; Pandya AP; Harada H; Powis G; Chen CS; Koumenis C; Grant S; Dent P
Mol Pharmacol; 2006 Aug; 70(2):589-603. PubMed ID: 16622074
[TBL] [Abstract][Full Text] [Related]
10. OSU-03012 in the treatment of glioblastoma.
McCubrey JA; Lahair MM; Franklin RA
Mol Pharmacol; 2006 Aug; 70(2):437-9. PubMed ID: 16675657
[TBL] [Abstract][Full Text] [Related]
11. The Small Molecule Inhibitor QLT-0267 Decreases the Production of Fibrin-Induced Inflammatory Cytokines and Prevents Post-Surgical Peritoneal Adhesions.
Fang CC; Chou TH; Huang JW; Lee CC; Chen SC
Sci Rep; 2018 Jun; 8(1):9481. PubMed ID: 29930281
[TBL] [Abstract][Full Text] [Related]
12. Integrin-linked kinase is dispensable for multiple myeloma cell survival.
Steinbrunn T; Siegmund D; Andrulis M; Grella E; Kortüm M; Einsele H; Wajant H; Bargou RC; Stühmer T
Leuk Res; 2012 Sep; 36(9):1165-71. PubMed ID: 22658851
[TBL] [Abstract][Full Text] [Related]
13. An increase in integrin-linked kinase non-canonically confers NF-κB-mediated growth advantages to gastric cancer cells by activating ERK1/2.
Tseng PC; Chen CL; Shan YS; Chang WT; Liu HS; Hong TM; Hsieh CY; Lin SH; Lin CF
Cell Commun Signal; 2014 Nov; 12():69. PubMed ID: 25398317
[TBL] [Abstract][Full Text] [Related]
14. Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536.
Gleixner KV; Ferenc V; Peter B; Gruze A; Meyer RA; Hadzijusufovic E; Cerny-Reiterer S; Mayerhofer M; Pickl WF; Sillaber C; Valent P
Cancer Res; 2010 Feb; 70(4):1513-23. PubMed ID: 20145140
[TBL] [Abstract][Full Text] [Related]
15. A novel HIF-1α-integrin-linked kinase regulatory loop that facilitates hypoxia-induced HIF-1α expression and epithelial-mesenchymal transition in cancer cells.
Chou CC; Chuang HC; Salunke SB; Kulp SK; Chen CS
Oncotarget; 2015 Apr; 6(10):8271-85. PubMed ID: 25821081
[TBL] [Abstract][Full Text] [Related]
16. mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.
Avila CL; Zimmerer JM; Elzein SM; Pham TA; Abdel-Rasoul M; Bumgardner GL
Transplantation; 2016 Sep; 100(9):1898-906. PubMed ID: 27362313
[TBL] [Abstract][Full Text] [Related]
17. Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival.
Troussard AA; McDonald PC; Wederell ED; Mawji NM; Filipenko NR; Gelmon KA; Kucab JE; Dunn SE; Emerman JT; Bally MB; Dedhar S
Cancer Res; 2006 Jan; 66(1):393-403. PubMed ID: 16397254
[TBL] [Abstract][Full Text] [Related]
18. The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptor.
To K; Zhao Y; Jiang H; Hu K; Wang M; Wu J; Lee C; Yokom DW; Stratford AL; Klinge U; Mertens PR; Chen CS; Bally M; Yapp D; Dunn SE
Mol Pharmacol; 2007 Sep; 72(3):641-52. PubMed ID: 17595327
[TBL] [Abstract][Full Text] [Related]
19. Effects of the novel and potent lymphocyte-specific protein tyrosine kinase inhibitor TKM0150 on mixed lymphocyte reaction and contact hypersensitivity in mice.
Takayama T; Takaoka A; Takahashi S; Takahashi A; Umemiya H; Sato M
Arzneimittelforschung; 2010; 60(5):282-5. PubMed ID: 20533766
[TBL] [Abstract][Full Text] [Related]
20. Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells.
Gao J; Zhu J; Li HY; Pan XY; Jiang R; Chen JX
Int J Biochem Cell Biol; 2011 Sep; 43(9):1294-304. PubMed ID: 21601006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
